- Home
- CLST vs KZR Comparison
CLST vs KZR Comparison
Compare CLST & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- KZR
- Stock Information
- Founded
- CLST 1922
- KZR 2015
- Country
- CLST United States
- KZR United States
- Employees
- CLST N/A
- KZR N/A
- Industry
- CLST
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- CLST
- KZR Health Care
- Exchange
- CLST Nasdaq
- KZR Nasdaq
- Market Cap
- CLST 51.0M
- KZR 46.5M
- IPO Year
- CLST N/A
- KZR 2018
- Fundamental
- Price
- CLST $11.63
- KZR $6.22
- Analyst Decision
- CLST
- KZR Hold
- Analyst Count
- CLST 0
- KZR 2
- Target Price
- CLST N/A
- KZR $9.00
- AVG Volume (30 Days)
- CLST 5.1K
- KZR 32.9K
- Earning Date
- CLST 01-23-2025
- KZR 03-13-2025
- Dividend Yield
- CLST N/A
- KZR N/A
- EPS Growth
- CLST N/A
- KZR N/A
- EPS
- CLST N/A
- KZR N/A
- Revenue
- CLST $5,174,000.00
- KZR N/A
- Revenue This Year
- CLST N/A
- KZR N/A
- Revenue Next Year
- CLST N/A
- KZR N/A
- P/E Ratio
- CLST N/A
- KZR N/A
- Revenue Growth
- CLST N/A
- KZR N/A
- 52 Week Low
- CLST $10.78
- KZR $5.20
- 52 Week High
- CLST $12.10
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- CLST 47.85
- KZR 40.84
- Support Level
- CLST $11.41
- KZR $6.35
- Resistance Level
- CLST $11.84
- KZR $6.65
- Average True Range (ATR)
- CLST 0.10
- KZR 0.24
- MACD
- CLST -0.00
- KZR 0.02
- Stochastic Oscillator
- CLST 51.16
- KZR 14.00
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a federally chartered community-oriented savings bank. The bank is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources which are used for the origination of loans. The Bank derives its income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.